suma/补品

CROSS-REFERENCE TO RELATED APPLICATION This application is the U.S. National Phase under 35 U.S.C. .sctn. 371 of International Application PCT/JP2015/051115, filed Jan. 16, 2015, which is based upon and claims the benefit of priority of the prior Japanese Patent Application No. 2014-006171, filed on

FIELD OF THE DISCLOSURE The present disclosure is related to new medical uses of the synthetic neurosteroid analogue ganaxolone. BACKGROUND Ganaxolone (3.alpha.-hydroxy-3.beta.-methyl-5.alpha.-pregnan-20-one, (3.alpha., 5.alpha.)-3-hydroxy-3-methylpregnan-20-one, or CCD 1042) is a synthetic

FIELD OF THE DISCLOSURE The present disclosure is related to new medical uses of the synthetic neurosteroid analogue ganaxolone. BACKGROUND Ganaxolone (3.alpha.-hydroxy-3.beta.-methyl-5.alpha.-pregnan-20-one, (3.alpha.,5.alpha.)-3-hydroxy-3-methylpregnan-20-one, or CCD 1042) is a synthetic

BACKGROUND OF THE INVENTION 1. Field of the Invention The present application concerns natural products and more especially valuable materials that can be derived from the byproducts of vinification. 2. Description of Related Art Currently there is a growing concern on the part of the public that

BACKGROUND OF THE INVENTION 1. Field of the Invention The present application concerns natural products and more especially valuable materials that can be derived from the byproducts of vinification. 2. Description of Related Art Currently there is a growing concern on the part of the public that